Name: Aardvark Therapeutics, Inc. (AARD) Balance Sheet
Creator: FinSpry

Aardvark Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aardvark Therapeutics, Inc. (AARD) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	61.64	9.74	15.56
Short-Term Investments	12.02	0.25	0.55
Cash & Short-Term Investments	73.66	9.99	16.11
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.16	0.13	0.07
Total Current Assets	74.14	10.37	16.49
Non-Current Assets
Property, Plant & Equipment (Net)	0.74	0.16	0.25
Other Non-Current Assets	2.64	0.01	0.01
Total Non-Current Assets	3.37	0.17	0.27
Total Assets	77.51	10.54	16.76
Current Liabilities
Accounts Payable	2.30	1.04	0.26
Short-Term Debt	0.34	0.00	0.00
Accrued Liabilities	1.40	0.19	0.18
Other Current Liabilities	2.29	0.00	0.00
Total Current Liabilities	4.93	1.38	0.60
Non-Current Liabilities
Long-Term Debt	0.44	0.05	0.16
Other Non-Current Liabilities	0.03	0.00	0.02
Total Non-Current Liabilities	127.22	43.96	44.09
Total Liabilities	132.15	45.34	44.68
Stockholders' Equity
Retained Earnings	-58.33	-37.74	-30.53
Additional Paid-in Capital	3.68	2.94	2.61
Shares Outstanding	21.69	21.38	21.38
Total Stockholders' Equity	-54.64	-34.80	-27.92
Total Liabilities & Equity	77.51	10.54	16.76